SIMPATHIC
Our Team
Prof. Dr. Peter-Bram ’t Hoen
Professor of Bioinformatics, Department of Medical BioSciences, Radboud university medical center, Nijmegen, The Netherlands
Project coordinator SIMPATHIC
Prof. Dr. Clara DM van Karnebeek
Pediatrician Metabolic Diseases & Biochemical Geneticist
Principal Investigator | Depts Pediatrics & Humans Genetics
Director Emma Center for Personalized Medicine
Director United for Metabolic Diseases
Depts Pediatrics & Humans Genetics
Amsterdam Medical Center,
Amsterdam, The Netherlands
Project coordinator SIMPATHIC
| Workgroup leader “Clinical trial design and execution"
Dr. Jurriaan Zwier
Grant Manager Medical Neuroscience
Radboud university medical center
Nijmegen, The Netherlands
Project manager SIMPATHIC
Dr. Pascale Milani
Communication and Philanthropy manager
Foundatin For Rare Diseases
Paris, France
Communication manager SIMPATHIC
Dr. Laura Benkemoun
Research Advisor for patient organizations
FFRD - Foundation For Rare Diseases (Fondation Maladies Rares)
Paris, France
Workgroup leader
“Patient empowerment, outcome measures, ethics”
Dr. Ibrahim Boussaad
Department of Translational Neoroscience
Centre for Systems Biomedicine
University of Luxembourg
Esch-sur-Alzette, Luxembourg
Workgroup leader “Drug screening”
Dr. rer. nat. Sabine Jung-Klawitter
Graduate biologist
Centre for Paediatrics and Adolescent Medicine
Dietmar Hopp Metabolism Centre
Head of the Neurotransmitter Research Group
Heidelberg University Hospital
Heidelberg, Germany
Workgroup leader
“Disease models and cellular and molecular profiling”
Dr. Martin de Kort
Senior Scientific Program Manager at EATRIS ERIC Scientific Officer Drug Repurposing Amsterdam, The Netherlands
Multistakeholder Advisory Board
Pr. Dr. med. Benedikt Schoser Fean
Friedrich Baur Institute Neurological Clinic and Polyclinic LMU Hospital Ludwig-Maximilians-University Munich,Germany
Dr. Claudia Fuchs
Drug Repurposing Projects Senior Manager
EURORDIS - Rare Diseases Europe, Italy
Prof. Dr. med. Dipl.-Psych. Martina Huemer
Division of Metabolism, Children’s Research Centre, University Children’s Hospital Zurich, University of Zurich, Zurich, Switzerland & Department of Paediatrics, LKH Bregenz, Bregenz , Austria
Pr. Dr. H.G.M.(Bert) Leufkens
Emeritus Professor of Pharmaceutical Policy and Regulatory Science Utrecht University
Dr. Deborah Mascalzoni
Associate Professor of Biomedical Ethics, Center for Research Ethics and Bioethics, Uppsala University, Sweden and Research Group Leader at the Institute for Biomedicine, EURAC Research, Italy
Dr. Violeta Stoyanova-Beninska
Office of Therapies for neurological and psychiatric disorders Human Medicines Division European Medicines Agency, The Netherlands
Paola Morandi
Patient representative for mitochondrial eye diseases International Mito Patients, Italy
Dr Ourania Zygogianni
Strategic Project Manager, Corporate Strategy Elpen Pharmaceutical Co Inc, Athens, Greece
Dr Teresinha Evangelista
ERN EURO-NMD Coordinator
Neuromuscular pathology functional unit, neuropathology department and Centre de Référence des maladies neuromusculaires Nord/Est/Ile-de-France, Hôpital Pitié-Salpêtrière, Paris, France
MAB Coordination
Pr. Dr. med. Dipl.-Psych. Martina Cornel
Senior Physician, Department of Metabolic Diseases Professor of Community Genetics & Public Health Genomics Dept. Human Genetics & Amsterdam Public Health research institute Amsterdam UMC,The Netherlands